Ride, Run, or Walk for a Future Immune to Cancer Join us on June 10 in West Point, NY!
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Data from four CRI-funded early-phase immunotherapy combination trials will be presented at the American Society for Clinical Oncology (ASCO) Annual meeting in Chicago in June.
Nonprofit Cancer Research Institute appoints pharmaceutical executive to lead its clinical research program
An innovative collaboration model designed to accelerate next-generation precision cancer immunotherapy through network of leading research centers and top scientists
CRI iAtlas to provide immune bioinformatics tool that aims to improve cancer immunotherapy research and drug effectiveness.
The two nonprofits partnered to support four scientists whose research is focused on developing immunotherapies for patients with fibrolamellar hepatocellular carcinoma.
National Headquarters | One Exchange Plaza
55 Broadway, Suite 1802 | New York, NY 10006
(800) 992-2623(212) 832-9376Staff Directory
Patients in the U.S. who have advanced nonsquamous non-small cell lung cancer can now receive Keytruda as part of initial treatment regardless of PD-L1 expression
New study reveals effectiveness of immunotherapy vaccine against aggressive ovarian tumors